Date: Saturday, November 6
Time: 7:30 am to 1:00 pm
CME: 5.5 CME credits are available for attendees
This half-day continuing education session is designed for health care professionals involved in the identification, diagnosis, and treatment of prostate cancer. The session will provide attendees with an opportunity to learn about recent evidence-based treatment advancements and leading edge technologies being utilized to effectively enhance outcomes for prostate cancer patients.
Attendees of this symposium will receive practical, clinical information through presentations, case reviews, and through an interactive expert panel discussion. The symposia material was selected to further educate healthcare practitioners on evidence-based approaches that will help improve clinical practice and increase awareness of treatment options.
This symposium is designed for health care practitioners, including physicians, surgeons, physician assistants, and nurse practitioners in the following specialties:
National experts will lead discussions about recent evidence-based treatment advancements and technologies being utilized in treating prostate cancer. Attendees of this symposium will receive practical, clinical information through presentations, case reviews, and through and interactive expert panel discussion.
CME: 5.5 Credits
This activity has been planned and implemented in accordance with the Essential Areas and Polices of the Medical Society of the State of New York (MSSNY) through the joint sponsorship of the Westchester Academy of Medicine (WAM) and Northern Westchester Hospital. The WAM is accredited by the MSSNY to provide continuing Medical Education for physician. The WAM designates this educational activity for a maximum of 5.5 AMA/PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. The Westchester Academy of Medicine adheres to ACCME standards regarding commercial support of continuing medical education. All speakers participating in Continuing Medical Education activities are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentations.